Clinical Trial

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

Name: A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B — clinical trial record (NCT07730567)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the pharmacokinetic interaction and the safety of AD-236A and AD-236B in healthy adult volunteers

Trial Details

NCT Number	NCT07730567
Lead Sponsor	Addpharma Inc.
Conditions	Hyperlipidemia, Diabete Type 2
Enrollment	44 participants
Start Date	2026-07-29
Primary Completion	2026-09-13 (estimated)
Study Completion	2026-09-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-28